Navigation Links
SGX Initiates Phase I Trials for SGX523
Date:1/16/2008

SAN DIEGO, Jan. 16 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) today announced that it has opened enrollment in two Phase I studies, with the first patient being treated on January 14, 2008. The Phase I studies are designed to evaluate the safety, tolerability and pharmacokinetic profile of SGX523, an internally developed, orally-bioavailable, small molecule inhibitor of the cMET receptor tyrosine kinase.

The Phase I clinical trials are open-label, dose escalation studies of SGX523 administered orally to patients with advanced cancer who have either failed standard therapy or for whom no standard therapy exists. The studies are designed to explore two dosing regimens in parallel. The continuous dosing trial will have continuous uninterrupted twice daily dosing with patients being evaluated every 28 days for continuation of treatment. The intermittent dosing schedule will implement twice daily dosing on a 14 days on/7 days off therapy schedule, cycling every 21 days. In both protocols, patients may continue on therapy for up to 12 months as determined by the patient's response and tolerance to SGX523.

"SGX523 is our first internally discovered clinical candidate. We are excited to begin studying SGX523 in humans and to achieve the first of our 2008 clinical development goals," said Mike Grey, President and Chief Executive Officer of SGX Pharmaceuticals. "With two separate dosing schedules, we believe that we will be able to collect important data that could serve as a basis for future clinical development activities and position us to capitalize on the evolving cMET opportunity."

About SGX523 and cMET

SGX523 has shown exceptional selectivity for the cMET receptor tyrosine kinase over more
'/>"/>

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
2. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
3. Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure
4. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
5. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
6. Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer
7. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
8. Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia
9. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
10. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
11. Glenmark Initiates Phase 2 Trial for Crofelemer for Acute Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... MUNSTER, Ind. , Sept. 30, 2014  The orthopedic ... ranked the nation,s No. 6 orthopedic group by US ... for Active Adults," a series of free, public seminars ... from all over the world come to see the ... replacement procedures are now available at Munster Specialty Surgery ...
(Date:9/30/2014)... 2014 In 2011, approximately 5.1 million people ... prescription pain relievers (e.g. opioids). 1 Clinical treatments ... entails the use of buprenorphine, buprenorphine/naloxone, naltrexone or methadone. ... when developing and improving care management programs, according to ... Prime Therapeutics LLC (Prime). Cost ...
(Date:9/30/2014)... , Sept. 30, 2014 Headquartered in ... is a diversified company comprised of several specialized partners ... technology and the proven expertise of its team of ... wellness. WholeHealth Products, line of more than 10 professional ... and its more than 8 retail consumer tests is ...
Breaking Medicine Technology:"Knee Pain Solutions for Active Adults" Complimentary Seminars Open to the Public 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3WholeHealth Products Announces The Discovery Of The "Autism And Fragile X" Microwell And Rapid Diagnostic Test 2
... WOONSOCKET, R.I., Nov. 17, 2011 CVS Caremark (NYSE: ... Kevin Murphy to the position of President for Accordant ... management and case management services for people with rare ... leading rare disease management programs with its specialty pharmacy ...
... Today, Takeda Pharmaceuticals North America, Inc., (Takeda) announced ... from a study in healthy subjects demonstrating that ... to the active metabolite of clopidogrel or clopidogrel-induced ... necessary when administered with an approved dose of ...
Cached Medicine Technology:CVS Caremark Appoints Kevin Murphy President of Accordant Business 2DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 2DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 3DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 4DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 5
(Date:9/30/2014)... For most families, fall means back-to-school ... patch or annual festival. For millions of children, fall ... the respiratory infection Enterovirus D68. , While symptoms ... percentage – especially children with weakened immune systems – ... Enterovirus is prompting hospitals across the country to enact ...
(Date:9/30/2014)... 2014 A group of Americans is headed ... epidemic that, left unchecked, could create a catastrophic, global pandemic. ... to Africa. John Rogers, the Executive Director the Eugene Bell ... fight a disease most think mankind conquered long ago: tuberculosis. ... ago is on the comeback in several countries - what’s ...
(Date:9/30/2014)... -- Medicare should cover low-dose computed tomography lung cancer ... a coalition of more than 60 patient and medical ... Cancer Alliance, the Society of Thoracic Surgeons, the American ... American Society of Clinical Oncology, made its point in ... Medicare & Medicaid Services (CMS). Such screening reduces ...
(Date:9/30/2014)... causes a rare premature aging disease could lead to ... cell division that makes cancer so deadly. , ... Health System recently discovered a protein mutation that causes ... stem cells can,t regenerate and make new blood. People ... and bone marrow failure. , But the study ...
(Date:9/30/2014)... September 30, 2014 Healthpointe is proud ... performing advanced foot and ankle reconstruction surgeries to assist ... surgeon, Dr. Cortés specializes in the diagnosis and treatment ... . She is also trained to perform advanced Foot ... needs. Dr. Cortés is also fluent in Spanish. , ...
Breaking Medicine News(10 mins):Health News:As Hospitals Combat Enterovirus Outbreaks, Patients and Families Turn to “Virtual Visits” with CaringBridge 2Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2Health News:Groups Call for Medicare Coverage of Lung Cancer Screening 2Health News:Disease decoded: Gene mutation may lead to development of new cancer drugs 2Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 2Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 3
... have published practical, science-based strategies to help prevent the six most ... ... Wire EON) October 8, 2008 -- Preventing HAIs is one ... HAIs affect nearly 2 million Americans annually, with 90,000 deaths and ...
... The Hain Celestial,Group, Inc. (Nasdaq: HAIN ), ... products company, today announced that Irwin Simon, President ... presentation regarding the,Company on Wednesday, October 15, 2008 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050324/NYTH131 ), The ...
... President,s Challenge and National Association for Sport and Physical ... ... Washington ... 8 NFL Network is launching Keep Gym,in School, a national initiative dedicated ...
... Robbins & Myers, Inc.,(NYSE: RBN ) ... a regular,cash dividend payment of $0.0375 per share. ... shareholders of record as of October 20, 2008., ... supplier of engineered equipment and,systems for critical applications ...
... Friday, WASHINGTON, Oct. 8 Around 13,000 ... Oct. 25-29, to address,the nation,s top public health ... Annual Meeting., The conference will feature leading ... science at nearly a,thousand sessions on significant public ...
... physical activity guidelines,released today by the U.S. Department ... the information they need to achieve and maintain ... national resource office for the,nation,s 2,686 not-for-profit YMCAs., ... set achievable,goals for everyone and can be customized ...
Cached Medicine News:Health News: Nation's Top Healthcare Organizations Announce Strategies to Prevent Deadly Healthcare-Associated Infections : Strategies emphasize practical implementation in acute healthcare settings 2Health News: Nation's Top Healthcare Organizations Announce Strategies to Prevent Deadly Healthcare-Associated Infections : Strategies emphasize practical implementation in acute healthcare settings 3Health News: Nation's Top Healthcare Organizations Announce Strategies to Prevent Deadly Healthcare-Associated Infections : Strategies emphasize practical implementation in acute healthcare settings 4Health News:Hain Celestial to Present at Canaccord Adams Healthy Living Naturally Boston Conference on October 15, 2008 2Health News:NFL Network Tackles Youth Fitness With New National Initiative to 'Keep Gym in School' 2Health News:NFL Network Tackles Youth Fitness With New National Initiative to 'Keep Gym in School' 3Health News:NFL Network Tackles Youth Fitness With New National Initiative to 'Keep Gym in School' 4Health News:Thousands of Public Health Experts to Address Leading Issues at APHA Annual Meeting, Oct. 25-29 2Health News:YMCA of the USA Supports New National Physical Activity Guidelines 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: